DELAFIELD, Wis. (Stockpickr) -- There isn't a day that goes by on Wall Street when certain stocks trading for $10 a share or less don't experience massive spikes higher. Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.
Just take a look at some of the hot movers in the under-$10 complex from Thursday, including Neurometrix (NURO), which is soaring by 38%; OCZ Technology (OCZ), which is ripping higher by 21%; Westell Technologies (WSTL), which is soaring by 19%; and Merrimack Pharmaceuticals (MACK), which is spiking up by 17%. You don't even have to catch the entire move in lower-priced stocks such as these to make outsized returns when trading.
Guess what happened? Shares of Higher One didn't wait long to trigger that breakout, since the stock took out those key overhead resistance levels the following week. Shares of ONE are now exploding higher today and launching cleanly above all near-term overhead resistance levels with large upside volume. This stock has tagged an intraday high today of $9.99 a share, which represents a huge gain of close to 30% from the time of this writing. This stock now has a great a chance to hit $11 to $12 in the coming weeks, so make sure to keep this name on your radar.
Low-priced stocks are something that I tweet about on a regular basis. I frequently flag high-probability setups, breakout candidates and low-priced stocks that are acting technically bullish. I like to hunt for low-priced stocks that are showing bullish price and volume trends, since that increases the probability of those stocks heading higher. These setups often produce monster moves higher in very short time frames.
I'm not as eager to recommend investing long-term in stocks that trade less than $10 a share because these names can be very speculative, and the odds for picking the long-term winners aren't great. But I definitely love to trade stocks that are priced below $10. I like to view them as a trading vehicle with lots of volatility and lots of upside when the trade is timed right.
When I trade under-$10 names, I do it almost entirely based off of the charts and technical analysis. I also like to find under-$10 names with a catalyst, but that's secondary to the chart and volume patterns.
With that in mind, here's a look at several under-$10 stocks that look poised to potentially trade higher from current levels.
Nanosphere
One under-$10 medical equipment player that's quickly moving within range of triggering a major breakout trade is Nanosphere (NSPH), which develops, manufactures and markets an advanced molecular diagnostics platform, the Verigene System, which enables simple, low-cost and highly sensitive genomic and protein testing on a single platform. This stock has been hit hard by the bears so far in 2013, with shares off by 27%.
If you take a look at the chart for Nanosphere, you'll notice that this stock is just starting to spike sharply higher today back above its 50-day moving average of $2 a share. This spike is quickly pushing shares of NSPH within range of triggering a major breakout trade. That breakout will trigger once NSPH manages to take out the upper-end of its recent sideways trading chart pattern.
Traders should now look for long-biased trades in NSPH if it manages to break out above some near-term overhead resistance levels at $2.17 to $2.20 a share and then once it takes out its gap down day high from August at $2.29 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 652,718 shares. If that breakout hits soon, then NSPH will set up to re-fill some of its previous gap down zone from August that stated just above $3 a share. If that gap gets filled with volume, then NSPH could easily tag $3.50 to $4 a share.
Traders can look to buy NSPH off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $1.81 to $1.77 a share. One can also buy NSPH off strength once it clears those resistance levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Castle Brands
Another stock that's rapidly moving within range of triggering a big breakout trade is Castle Brands (ROX), which develops and markets premium and super-premium brands in the beverage alcohol categories: rum, whiskey, liqueurs, vodka, tequila and fine wine. This stock has been on fire so far in 2013, with shares up huge by 234%.
If you take a look at the chart for Castle Brands, you'll notice that this stock has been uptrending very strong for the last three months, with shares soaring higher from its low of 30 cents per share to its recent high of 99 cents per share. During that uptrend, shares of ROX have been consistently making higher lows and higher highs, which is bullish technical price action. That move has now pushed shares of ROX within range of triggering a big breakout trade.
Market players should now look for long-biased trades in ROX if it manages to break out above some near-term overhead resistance levels at 93 cents per share to its 52-week high at 99 cents per share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 501,958 shares. If that breakout triggers soon, then ROX will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $1.50 to $2 a share.
Traders can look to buy ROX off any weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at 80 cents to 77 cents per share, or around its 50-day at 70 cents per share. One can also buy ROX off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Stereotaxis
One under-$10 health care player that looks poised for a potentially large move higher is Stereotaxis (STXS), which designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. This stock has been on fire so far in 2013, with shares up big by 43%.
If you take a look at the chart for Stereotaxis, you'll notice that this stock has formed a major bottom pattern over the last three months, since this stock has found buying interest each time it has pulled back towards $3.50 and $3.10 a share. Buyers have stepped in at those levels and have not let the sellers pressure STXS lower. Shares of STXS are now starting to spike higher today right off its 50-day moving average of $3.59 a share. That spike is quickly pushing shares of STXS within range of triggering a big breakout trade above a key downtrend line.
Traders should now look for long-biased trades in STXS if it manages to break out above some near-term overhead resistance at $4 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 1.98 million shares. If that breakout triggers soon, then STXS will set up to re-test or possibly take out its next major overhead resistance levels at $5 to $6.24 a share. Any high-volume move above $6.24 a share will then give STXS a chance to re-fill some of its previous gap down zone from August that started at $10 a share.
Traders can look to buy STXS off any weakness to anticipate that breakout and simply use a stop that sits right below those key support levels at $3.50 to $3.10 a share. One can also buy STXS off strength once it clears $4 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
Fuel Tech
Another under-$10 stock that's starting to move within range of triggering a big breakout trade is Fuel-Tech (FTEK), which uses a suite of advanced technologies to provide boiler optimization, efficiency improvement and air pollution reduction and control solutions to utility and industrial customers. This stock is off to a slow start in 2013, with shares up just 7% so far.
If you take a look at the chart for Fuel Tech, you'll notice that this stock has entered a tight consolidation chart pattern over the last month, with shares moving between $4.19 on the downside and $4.78 a share on the upside. Shares of FTEK are now starting to trend higher and move within range of triggering a big breakout trade above the upper-end of its recent sideways trading chart pattern.
Market players should now look for long-biased trades in FTEK if it manages to break out above some near-term overhead resistance levels at $4.66 to $4.68 a share and then once it takes out more resistance at $4.78 to its 52-week high at $5.20 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average action of 77,549 shares. If that breakout hits soon, then FTEK will set up to enter new 52-week high territory, which is bullish technical price action. Some possible upside targets of that breakout are $5.50 to $6, or even $7 a share.
Traders can look to buy FTEK off weakness to anticipate that breakout and simply use a stop that sits right below its 50-day at $4.33 a share, or just below its 200-day at $4.14 a share. One can also buy FTEK off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.
NuPathe
One final under-$10 pharmaceuticals player that's quickly moving within range of triggering a near-term breakout trade is NuPathe (PATH), which develops and commercializes branded therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. This stock has been hammered by the sellers in 2013, since shares of are off sharply by 48%.
If you take a look at the chart for NuPathe, you'll notice that this stock has been downtrending badly for the last four months, with shares plunging lower from its high of $3.09 to its recent low of $1.57 a share. During that downtrend, shares of PATH were consistently making lower highs and lower lows, which is bearish technical price action. That said, shares of PATH have now started to reverse that downtrend, and we could be seeing an end to the downside volatility in the short-term. That reverse is starting to push shares of PATH within range of triggering a near-term breakout trade.
Traders should now look for long-biased trades in PATH if it manages to break out above some near-term overhead resistance at $1.79 a share with high volume. Look for a sustained move or close above that level with volume that hits near or above its three-month average action of 150,366 shares. If that breakout hits soon, then PATH will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day of $2.21 to $2.50 a share.
Traders can look to buy PATH off weakness to anticipate that breakout and simply use a stop that sits right below some key near-term support levels at $1.65 or at $1.57 a share. One can also buy PATH off strength once it clears $1.79 a share with volume and then simply use a stop that sits a comfortable percentage from your entry point.
To see more hot under-$10 equities, check out the Stocks Under $10 Setting Up to Explode portfolio on Stockpickr.
-- Written by Roberto Pedone in Delafield, Wis.
No comments:
Post a Comment